Timothy P. Zannes - Aug 29, 2022 Form 3 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role
Secretary, EVP, Gen. Counsel
Signature
/s/ Wilhelm E. Liebmann, as attorney-in-fact for Timothy P. Zannes
Stock symbol
BIAF
Transactions as of
Aug 29, 2022
Transactions value $
$0
Form type
3
Date filed
12/5/2022, 03:27 PM
Next filing
Dec 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BIAF Stock Option (right to buy) Aug 29, 2022 Common Stock 64.8K $1.16 Direct F1, F2
holding BIAF Stock Option (right to buy) Aug 29, 2022 Common Stock 1.43K $7.00 Direct F1, F3
holding BIAF Stock Option (right to buy) Aug 29, 2022 Common Stock 4.29K $7.70 Direct F1, F4
holding BIAF Stock Option (right to buy) Aug 29, 2022 Common Stock 2.14K $7.70 Direct F1, F5
holding BIAF Stock Option (right to buy) Aug 29, 2022 Common Stock 2.14K $7.70 Direct F1, F6
holding BIAF Stock Option (right to buy) Aug 29, 2022 Common Stock 2.14K $7.70 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of securities and exercise prices reported in this Form 3 reflect the 1-for-7 reverse stock split of the common stock, par value $0.007 (the "Common Stock"), of bioAffinity Technologies, Inc. (the "Issuer"), which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering.
F2 Represents a right to purchase 64,848 shares of Common Stock upon exercise of a ten-year option granted to Mr. Zannes under the Issuer's 2014 Equity Incentive Plan (the "EIP") on April 28, 2014. This option vested in 7 monthly installments beginning on May 28, 2014 and is fully vested and exercisable as of the date of this report.
F3 Represents a right to purchase 1,428 shares of Common Stock upon exercise of a ten-year option granted to Mr. Zannes under the EIP on April 24, 2017. This option vested in 12 monthly installments beginning on May 24, 2017 and is fully vested and exercisable as of the date of this report.
F4 Represents a right to purchase 4,285 shares of Common Stock upon exercise of a ten-year option granted to Mr. Zannes under the EIP on May 7, 2018. This option vested in 12 monthly installments beginning on June 7, 2018 and is fully vested and exercisable as of the date of this report.
F5 Represents a right to purchase 2,142 shares of Common Stock upon exercise of a ten-year option granted to Mr. Zannes under the EIP on February 25, 2019. This option vested in 12 monthly installments beginning on March 25, 2019 and is fully vested and exercisable as of the date of this report.
F6 Represents a right to purchase 2,142 shares of Common Stock upon exercise of a ten-year option granted to Mr. Zannes under the EIP on February 5, 2020. This option vested in 12 monthly installments beginning on March 5, 2020 and is fully vested and exercisable as of the date of this report.
F7 Represents a right to purchase 2,142 shares of Common Stock upon exercise of a ten-year option granted to Mr. Zannes under the EIP on July 26, 2021. This option vested in 12 monthly installments beginning on August 26, 2021 and is fully vested and exercisable as of the date of this report.

Remarks:

Exhibit List - Exhibit 24.1: Power of Attorney (Timothy P. Zannes)